If you supply, mold, machine, assemble or package for a medical device OEM, chances are at least one of your competitors has changed ownership recently. But what does that mean for you?
In this MPO webinar, recorded on October 27, 2026, MedWorld Advisors’ Dave Sheppard, Florence Joffroy-Black and Daniel Sheppard look at who is doing that buying and why. Strategics, hybrids and private equity have moved decisively into the medtech supply chain, and the outsourcing base looks materially different than it did a few years ago. The panel lays out the shape of that consolidation, what’s driving it, and what it looks like from where you sit.
Watch the recording to learn why stakeholders of certain CDMOs obtain higher valuations than other medtech suppliers, and how industry dynamics are changing as independents compete against consolidated, well-capitalized platforms. You’ll also hear why a post-COVID, post-tariff supply chain has turned valuation into a global rather than a domestic conversation.
MedWorld Advisors works internationally with founders and business owners on the sell side of these transactions, representing the companies being acquired. Questions after watching? Reach out for a free, confidential conversation with our team.
